Low-Dose Alteplase May Be a Potential Treatment in Some But Not All Submassive Pulmonary Embolism: The Importance of an Abstract Conclusion.

Authors :: Meola G
Seabury R
Paolo W
Source :: Journal of pharmacy practice [J Pharm Pract] 2020 Dec; Vol. 33 (6), pp. 732-733. Date of Electronic Publication: 2020 May 01.
Publication Year :: 2020

Subjects :: Fibrinolytic Agents therapeutic use
Humans
Pulmonary Embolism diagnosis
Pulmonary Embolism drug therapy
Tissue Plasminogen Activator

Full Text Access

Tools